Does ABATACEPT Cause Malignant neoplasm progression? 136 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 136 reports of Malignant neoplasm progression have been filed in association with ABATACEPT (ORENCIA). This represents 0.1% of all adverse event reports for ABATACEPT.
136
Reports of Malignant neoplasm progression with ABATACEPT
0.1%
of all ABATACEPT reports
4
Deaths
4
Hospitalizations
How Dangerous Is Malignant neoplasm progression From ABATACEPT?
Of the 136 reports, 4 (2.9%) resulted in death, 4 (2.9%) required hospitalization, and 3 (2.2%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ABATACEPT. However, 136 reports have been filed with the FAERS database.
What Other Side Effects Does ABATACEPT Cause?
Drug ineffective (35,212)
Rheumatoid arthritis (21,898)
Pain (19,783)
Arthralgia (18,536)
Joint swelling (18,453)
Contraindicated product administered (13,559)
Fatigue (13,087)
Drug intolerance (12,451)
Rash (12,168)
Arthropathy (11,099)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which ABATACEPT Alternatives Have Lower Malignant neoplasm progression Risk?
ABATACEPT vs ABATACEPT SUBQ /ML
ABATACEPT vs ABCIXIMAB
ABATACEPT vs ABEMACICLIB
ABATACEPT vs ABILIFY
ABATACEPT vs ABIRATERONE